Literature DB >> 8303627

Relation of HIV-I in bronchoalveolar lavage cells to abnormalities of lung function and to the presence of Pneumocystis pneumonia in HIV-I seropositive patients.

J R Clarke1, I K Taylor, J Fleming, J D Williamson, D M Mitchell.   

Abstract

BACKGROUND: HIV is present in bronchoalveolar lavage cells of some but not all HIV seropositive patients. Abnormalities of lung function have been described in such patients in the absence of clinically overt pneumonia or other respiratory infections. It is possible that the presence of HIV in alveolar macrophages could account for these abnormalities. It is also possible that the presence of HIV in alveolar macrophages contributes to immunosuppression and an increased incidence of opportunistic infections.
METHODS: This was a prospective study of 157 HIV seropositive patients requiring diagnostic bronchoscopy for investigation of new respiratory symptoms, chest radiograph abnormality, or pneumonic illness. Presence of HIV in bronchoalveolar lavage cells obtained at diagnostic bronchoscopy was determined by polymerase chain reaction to detect proviral DNA and in vitro cocultivation to detect productive virus infection. With these two techniques the presence or absence of HIV in bronchoalveolar lavage was compared with the presence of abnormalities of lung function or presence of Pneumocystis pneumonia.
RESULTS: HIV was detected in bronchoalveolar lavage cells in 65% of patients by means of the polymerase chain reaction and 59% with cocultivation. With both methods of detection there was no association between the presence or absence of HIV and the presence of Pneumocystis pneumonia; nor was there a relation between the presence of HIV and abnormalities of lung function.
CONCLUSION: The presence of HIV in bronchoalveolar lavage cells does not predispose to an increased incidence of Pneumocystis pneumonia; nor does it contribute to abnormalities of lung function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8303627      PMCID: PMC464975          DOI: 10.1136/thx.48.12.1222

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  17 in total

1.  The human genome map 1990.

Authors:  J C Stephens; M L Mador; M L Cavanaugh; M I Gradie; K K Kidd
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

Review 2.  Pulmonary infectious complications of human immunodeficiency virus infection. Part I.

Authors:  J F Murray; J Mills
Journal:  Am Rev Respir Dis       Date:  1990-05

3.  Human T lymphotropic virus type III infection of human alveolar macrophages.

Authors:  S Z Salahuddin; R M Rose; J E Groopman; P D Markham; R C Gallo
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

4.  A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5.

Authors:  S Itescu; L J Brancato; J Buxbaum; P K Gregersen; C C Rizk; T S Croxson; G E Solomon; R Winchester
Journal:  Ann Intern Med       Date:  1990-01-01       Impact factor: 25.391

5.  Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis.

Authors:  R J Shaw; C Roussak; S M Forster; J R Harris; A J Pinching; D M Mitchell
Journal:  Thorax       Date:  1988-06       Impact factor: 9.139

6.  Human immunodeficiency virus recovery from bronchoalveolar lavage fluid in patients with AIDS.

Authors:  N C Dean; J A Golden; L A Evans; M L Warnock; T E Addison; P C Hopewell; J A Levy
Journal:  Chest       Date:  1988-06       Impact factor: 9.410

7.  The epidemiology of HIV-1 infection of the lung in AIDS patients.

Authors:  J R Clarke; I K Taylor; J Fleming; A Nukuna; J D Williamson; D M Mitchell
Journal:  AIDS       Date:  1993-04       Impact factor: 4.177

8.  Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients.

Authors:  B Autran; C M Mayaud; M Raphael; F Plata; M Denis; A Bourguin; J M Guillon; P Debre; G Akoun
Journal:  AIDS       Date:  1988-06       Impact factor: 4.177

Review 9.  Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination.

Authors:  F Plata; G Dadaglio; N Chenciner; A Hoffenbach; S Wain-Hobson; F Michel; P Langlade-Demoyen
Journal:  Immunodefic Rev       Date:  1989

10.  Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV).

Authors:  F P Ognibene; H Masur; P Rogers; W D Travis; A F Suffredini; I Feuerstein; V J Gill; B F Baird; J A Carrasquillo; J E Parrillo
Journal:  Ann Intern Med       Date:  1988-12-01       Impact factor: 25.391

View more
  4 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

Review 2.  AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.

Authors:  J R Clarke; D S Robinson; R J Coker; R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

3.  Interactions between opportunistic micro-organisms and HIV in the lung.

Authors:  J R Clarke; D Israel-Biet
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

4.  BAL fluid analysis and HIV-1 infection.

Authors:  J R Clarke; J D Williamson; D M Mitchell
Journal:  Thorax       Date:  1995-06       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.